Clinical Trial Update: ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression [Phase 1, Phase 2]

View source ↗

Summary

Overview of ELE-101 safety and tolerability evaluated in healthy volunteers and individuals with Major Depressive Disorder in Phase 1/2, currently not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ELE-101

Snippet

Sponsor: Eleusis Therapeutics | Conditions: Healthy Volunteers, Major Depressive Disorder | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING